The crystal structure of the parallel-stranded propeller-loop topology (PDB 1KF1) human 2 Electrostatic contributions to the overall binding energy were calculated using the APBS software, employing an implicit solvent model. 3 The docked complexes were prepared using the PDB2PQR server (http://agave.wustl.edu/pdb2pqr). Charges, atom types and radii were assigned to each ligand atom based on the AMBER force field. The complexes were then subjected to APBS electrostatic calculations. A dielectric constant of 2, a solvent dielectric constant of 80 were used, together with grid spacing that were all optimally chosen such that the grid was always finer than 0.5 Å. The remaining parameters were kept at default
(Eq. S3) (Eq. S4)
The data were recorded at a cone voltage of 50 V, and three different RF lens voltages (75V, 100V and 125 V). The spectra shown consist in a sum of at least 150 scans, processed as follows using MassLynx 4.0 software: smoothing (2 x mean, 20 channels), backgroundsubtraction (polynomial order = 10, 1% below curve). For peak area determination, the spectra were converted to centroid.
Typical spectra are shown in Figure S1 . The 1:1 complex was the only complex detectable.
The K d s reported in main text Table 1 
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Competition experiment
For the competition experiment, the mixtures injected contained 5 µM of duplex (dCGCGAATTCGCG) 2 , 5 µM of intramolecular telomeric quadruplex dAGGG(TTAGGG) 3 , 5 µM of tetramolecular quadruplex [dTGGGGT] 4 , 10 µM of ligand, and 2 µM of single strand dT 6 which is added as an intensity reference. The data were recorded at 3 different sets of voltages: [cone 50 V, RF lens 60 V]; [cone 100 V, RF lens 60 V]; [cone 100 V, RF lens 100 V]. The spectra shown consist in a sum of at least 150 scans, processed as follows using MassLynx 4.0 software: smoothing (2 x mean, 8 channels), background-subtraction (polynomial order = 50, 1% below curve). For peak area determination, the spectra were converted to centroid.
Typical spectra are shown in Figure S2 . The spectrum with no ligand (Fig. S2(a) ) shows peaks of the reference at m/z = 880.15. The intensity changes of free quadruplex or duplex upon ligand addition will be monitored compared to the intensity of the peak of dT 6 2-. The duplex is detected at charge states 5-and 4-(the peak at m/z = 1214.31 corresponds to the single strand with three charges, as deduced from the isotope pattern, not shown). The quadruplexes are detected at charge states 6-, 5-and 4-. The charge state 5-is the most intense for all target DNAs, and was used for the quantitation of free DNA.
Each day, a spectrum of the mixture without ligand was recorded, and the areas of the peaks of DNA (DNA stands for the duplex or one of the quadruplexes) and the peak of the reference strand were recorded. The experiments were then conduced with each ligand at 10 µL and the peak areas are measured. The data presented in main text Figure 1 is the fraction of free duplex or quadruplex after ligand addition, which was calculated as follows:
(Eq.
S5) 6
The fraction of free DNA is therefore deduced solely from the peak areas of the free species.
The mass spectra however provide further information on the nature of the complexes responsible for the diminishing of the peak areas of the free species. For example, in the case of ligand 14 ( Fig. S2(b) ), the tel22 quadruplex is consumed by forming a 1:1 complex with the ligand. In contrast, the [TG 4 T] 4 quadruplex forms not only 1:1 complex with the ligand, but also dimers (2Q + 2 to 4 ligands), detected at charge state 7-. The formation of these higher-order aggregates of [TG 4 T] 4 was detected with all ligands that significantly deplete the amount of free [TG 4 T] 4 quadruplex (ligands 6, 9, 10, 13 and 14). Note that all these ligands have para substituents. .
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F igure S3:
The excellent correlation between the K d for ligand binding to tel22 and determination and the fraction free tel22 found in the competition experiment shows that the competition experiment is a reliable way to assess relative ligand binding affinities for several DNA structures at the same time.
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Absence of binding to the duplex (dCGCGAATTCGCG) 2 We attempted to determine the K d values of ligand binding to the duplexes in order to calculate the selectivity of the ligands for the telomeric quadruplex. We ran mixtures of reference + 5 µM (dCGCGAATTCGCG) 2 duplex + 40 µM ligand. A typical spectrum is shown in Figures S4 . We could detect no complex between the duplex and any of the ligands.
The presence of the ligand in the stock solutions was verified by testing their binding to the [TG 4 T] 4 quadruplex. We note a slight decrease of the signal of the duplex compared to the reference in the presence of 40 µM ligand. Because of the absence of detectable complex, we conclude that this change in relative intensities can be due to a change in the relative responses of dT 6 vs. duplex due to the presence of excess ligand.
In the absence of detectable complex, only a minimum limit value of the K d can be obtained from the background signal. From the noise level at m/z = 1635.90, we can estimate the minimum K d that would lead to a detectable complex, i.e. the K d that would lead to signal-tonoise ratio of 3 for the complex (assuming equal response factors for the duplex and the complex). By this procedure we deduce that all K d values for duplex binding are higher than 3000 µM. This gives a quadruplex/duplex selectivity ratio > 1000 for ligand 12, for example. Figure S4 : ESI-MS spectra of (a) 5 µM duplex (dCGCGAATTCGCG) 2 alone with 2 µM reference strand dT 6 , and of (b) 5 µM duplex (dCGCGAATTCGCG) 2 with 2 µM reference strand dT 6 and 40 µM of ligand 12. The 1:1 complex between the duplex and the ligand Table 1 .
Chemistry
General methods
Reagents, solvents and chemicals were purchased from Sigma-Aldrich, Alfa Aesar, GOSS, Lancaster Synthesis, Novabiochem, Avocado Organics or ABCR GMBH & CO (1,3,5-triethynylbenzene) and were used as supplied without further purification. All the organic solvents used for the reactions were purchased from VWR and Fisher scientific. Microwave irradiation was performed with an Initiator microwave (Biotage, Sweden). Flash chromatography was carried out with BDH silica gel (BDH 153325P).
HPLC analyses were performed using a Gilson apparatus combining a 322 PUMP and an Agilent 1100 SERIES detector. The column used was semi-prep reversed phase YMC-Pack ODS-A, phase C18, particle 5µm, pore 12 nm, ID 30 mm, length 100 mm, (AA12S05-1030WT, YMC, Japan).
LC/MS were performed using a Waters system combining a 2695 separation module, a
Micromass ZQ spectrometer and a 2996 photodiode array detector. Method description:
(5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) 
General procedure for the synthesis of nitrocompounds (2) a-k
The required nitroaniline (1 eq) was dissolved in THF and cooled down to 4 °C in ice bath.
To this stirred mixture first TEA (2 eq), then the appropriate acid chloride (1.2 eq) were added. The reaction was allowed to warm up to room temperature and after 2,30 hours the mixture was cooled down in ice bath, the appropriate amine was added (3 eq) and the reaction was stirred overnight at room temperature. After approx 14 hr (TLC 5% MeOH in DCM), the solvent was evaporated in vacuo. The crude was dissolved in DCM (75 ml), washed 3 times with saturated NaHCO 3 solution (50 ml), dried (MgSO 4 ) and taken to dryness. The crude obtained was purified by silica gel chromatography (0%-5% MeOH in DCM). 
2-(diethylamino)-N-(4-nitrophenyl)acetamide (2a)
3-(diethylamino)-N-(4-nitrophenyl)propanamide (2g)
4-Nitroaniline (1.00 g, 7.24 mmol), TEA (1.47 g, 14.50 mmol), 3- (CH 2 ), 45.95 (2 x CH 2 ), 32.89 (CH 2 ), 11.37 (2 x CH 3 ); LC-MS (5 min) m/z 266.43 [C 13 H 19 
N-(3-nitrophenyl)-4-(pyrrolidin-1-yl)butanamide (2i)
Compound ( 
General procedure for the synthesis of amino-compounds (3) a-k
The required compound (2) (1 eq) was dissolved in anhydrous THF in atmosphere of N 2 and 10% Pd/C (10% m/m) was added. The atmosphere was then saturated with H 2 and the mixture was stirred overnight. The crude was filtered on celite washing with EtOAc and the organic solution was evaporated in vacuo. The crude was dissolved in DCM (75 ml), washed 3 times with 5N aqueous NH 4 OH solution (50 ml), dried (MgSO 4 ) and taken to dryness. The product obtained was utilised in the next step without any further purification.
N-(4-aminophenyl)-2-(diethylamino)acetamide (3a)
Compound (2a) 
N-(4-aminophenyl)-2-(piperidin-1-yl)acetamide (3c)
Compound (2c 
N-(4-aminophenyl)-2-(pyrrolidin-1-yl)acetamide (3f)
Compound (2f) 
N-(3-aminophenyl)-4-(pyrrolidin-1-yl)butanamide (3i)
Compound (2i) 
N-(4-aminophenyl)-3-(dimethylamino)propanamide (3j)
Compound (2j) (3.00 g, 13.00 mmol) was dissolved in anhydrous 
N-(3-aminophenyl)-2-(pyrrolidin-1-yl)acetamide (3k)
Compound (2k 
General procedure for the synthesis of azides (4) a-k
The required compound (3) (1 eq) was dissolved in THF and cooled down in ice bath. This stirred mixture was treated first with HCl conc (5.5 eq), then with t BuONO (2.5 eq). The reaction was stirred in ice bath for 1.5 hours and after that time NaN 3 (3 eq) was added, followed by water, added very carefully until the fizz disappeared. The reaction was allowed to warm to room temperature and stirred overnight. The mixture was carefully neutralised with aqueous NaHCO 3 solution and THF was evaporated in vacuo. The aqueous solution was extracted three times with EtOAc (75 ml), dried (MgSO 4 ) and taken to dryness. The product obtained was utilised in the final step without any further purification.
N-(4-azidophenyl)-2-(diethylamino)acetamide (4a)
Compound (3a) (0.35 g, 1.60 mmol) was dissolved in THF (6 ml), 
N-(3-azidophenyl)-3-(pyrrolidin-1-yl)propanamide (4b)
Compound (3b) (1.07 g, 4.6 mmol) was dissolved in THF (10 ml), 
N-(4-azidophenyl)-2-(piperidin-1-yl)acetamide (4c)
Compound (3c) (0.59 g, 2.50 mmol) was dissolved in THF (6 ml), 
N-(3-azidophenyl)-2-(diethylamino)acetamide (4d)
Compound (3d) (0.52 g, 2.35 mmol) was dissolved in THF (6 ml), 
N-(4-azidophenyl)-2-(pyrrolidin-1-yl)acetamide (4f)
Compound (3f) (0.57 g, 2.61 mmol) was dissolved in THF (5 ml), Compound (3g) (0.45 g, 1.89 mmol) was dissolved in THF (15 ml), 
N-(4-azidophenyl)-3-(diethylamino)propanamide (4g)
N
N-(3-azidophenyl)-3-(diethylamino)propanamide (4h)
Compound (3h) (0.30 g, 1.27 mmol) was dissolved in THF (5 ml), 
N-(3-azidophenyl)-4-(pyrrolidin-1-yl)butanamide (4i)
N-(3-azidophenyl)-2-(pyrrolidin-1-yl)acetamide (4k)
Compound (3k) (0.66 g, 3.03 mmol) was dissolved in THF (10 ml), then HCl conc (1.39 ml, 16.67 mmol), t BuONO (0.78 g, 7.57 mmol) and NaN 3 (0.59 g, 9.10 mmol) were added, to afford (4k) as a dark 
Circular dichroism
Simultaneous UV & CD spectra of the 23mer DNA d[TA(GGGTTA) 2 GGG] alone and with compound 15 in sodium and potassium phosphate buffers (100 mM, pH = 7.4) were measured on the Applied Photophysics Ltd (Leatherhead, UK) Chirascan Plus spectrometer.
The UV absorbance & CD spectra were acquired between 400-220 nm in a rectangular 10mm
and 1mm cell pathlengths. The instrument was flushed continuously with pure evaporated nitrogen throughout the measurements. Spectra were recorded with a 1.0nm step size, a 1.0s measurement time-per-point and a spectral bandwidth of 2.0nm. All spectra were buffer baseline corrected and measured at 20 o C. All CD spectra were smoothed using the SavitzkyGolay method with a window factor of 4 for a better presentation. The appropriate volume of ligand 15 in the required buffer was added to a 2.2 µM DNA solution in the same buffer, in order to obtain DNA:drug ratios from 1:1 to 1:6. These mixtures were heated at 85 °C, and then gradually cooled to room temperature. The collected UV and CD spectra of these solutions are reported in Figure S5 . Figure S5 . CD and related UV spectra of DNA annealed in the presence of increasing concentrations of ligand 15 in sodium (left) and potassium (right) buffer. Although in sodium the structure did not display any significant changes at increasing drug concentrations, the curve in potassium showed a clear shift towards a parallel arrangement.
